Certificate number:RU.77.99.88.003.Е.000085.01.18 Date of registration and renewal:15.01.2018 Dosage form: & nbspCapsules of 560 mg. Classification "Composition" & nbsp BADs - fats, fatty substances and their derivatives Dietary supplements - proteins, amino acids and their derivatives Other dietary supplements Classification "Clinical" & nbsp Supplements promoting normalization and maintenance of normal intestinal microflora Composition: & nbspFennel ordinary (seed extract), Sagrada cascara (bark extract), ginger medicinal (root powder), senna alexandria (herb extract), rhubarb (root extract), oat bran, ordinary pumpkin (seed extract), citrus pectin (or apple) , buckthorn (alchoid) (extract), liquorice (licorice naked) (root powder), flax seeds (oil powder), bentonite (anti-caking agent, Е558), raw food "Lipofuel" (extract of cayenne pepper), microcrystalline cellulose (Е460 ) or lactose monohydrate, silica (E551), lactobacillus Acidophilus (Acidophilus), Acai (fruit powder), Aloe Capsicum (leaf powder), Aloe Vera (juice powder), Prunes (fruit powder); capsule shell (capsule "DRcapsTM" (E418, E464), or gelatine capsule of food or hydroxypropyl methylcellulose (E464), with or without the addition of a dye (and / or E140, E141, E160a, E162, E163, E171, E100, E101 , Е102, Е104, Е110, Е122, Е124, Е129, Е132, Е133, Е151, Е155). Scope: & nbspFor realization to the population as a biologically active additive to food - a source of anthraquinones (including aloe-emodin), glycyrrhizic acid, soluble dietary fiber containing essential oils. Suggested Usage: & nbspAdults take 5 capsules daily with meals. Duration of admission: 7 days. If necessary, the reception can be repeated in a month. Repeated receptions are possible throughout the year. Contraindications:Individual intolerance of components, pregnancy, breast-feeding, propensity to diarrhea, acute diseases of the gastrointestinal tract, intestinal obstruction, uterine bleeding. Before use, it is recommended to consult a doctor. Shelf life:2 years. Storage conditions:Store in a dry place inaccessible to children, at a temperature not exceeding + 25 ° С. Research protocols:Expert conclusion of the FBUC of the Federal Target Program and the Federal Service for Consumer Rights Protection No. 10FC / 5276 of December 29, 2017. ManufacturersV-MIN, LTD Russia Recipient:Pharmaceutical holding GI EL Medical, OOOPharmaceutical holding GI EL Medical, OOO Russian Federation Information update date: & nbsp14.02.2018 Instructions